Patents by Inventor Chih-Chung Tseng

Chih-Chung Tseng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATORS OF AMPA RECEPTOR SIGNALING
    Publication number: 20220185813
    Abstract: The present disclosure relates to compounds of the Formula (I) which have shown utility in modulating AMPA receptor signaling and thus preventing AMPA receptor-mediated toxicity, which may find use in the treatment of diseases in which AMPA receptor activation plays a role in neurodegeneration, including the treatment of multiple sclerosis and other diseases.
    Type: Application
    Filed: March 5, 2020
    Publication date: June 16, 2022
    Inventors: Fang Liu, lain Greig, Dongxu Zhai, Stephen Allan Smith, Chiara Zanato, Chih-Chung Tseng
  • Cannabinoid type 1 receptor modulators
    Patent number: 10377711
    Abstract: The present disclosure relates to indole derivatives of the formula (I) which are cannabinoid type 1 receptor modulators and which are useful in the treatment of diseases in which modulation of the receptor is beneficial; to processes for their preparation; to pharmaceutical compositions comprising them; and to methods of using them.
    Type: Grant
    Filed: August 26, 2015
    Date of Patent: August 13, 2019
    Assignees: The University Court of the University of Aberdeen, The Governing Council of the University of Toronto
    Inventors: Ruth Ross, Iain Greig, Matteo Zanda, Chih-Chung Tseng
  • CANNABINOID TYPE 1 RECEPTOR MODULATORS
    Publication number: 20180118681
    Abstract: The present disclosure relates to indole derivatives of the formula (I) which are cannabinoid type 1 receptor modulators and which are useful in the treatment of diseases in which modulation of the receptor is beneficial; to processes for their preparation; to pharmaceutical compositions comprising them; and to methods of using them.
    Type: Application
    Filed: August 26, 2015
    Publication date: May 3, 2018
    Inventors: Ruth Ross, Iain Greig, Matteo Zanda, Chih-Chung Tseng
  • FLUORO-PERHEXILINE COMPOUNDS AND THEIR THERAPEUTIC USE
    Publication number: 20160102058
    Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain fluoro-perhexiline compounds of the following formula (also referred to herein as FPER compounds) that are useful, for example, in the treatment of disorders (e.g., diseases) including, for example, those which are known to be treated with, or known to be treatable with, perhexiline, including, for example, disorders that are ameliorated by the inhibition of carnitine palmitoyltransferase (CPT); cardiovascular disorders such as: angina pectoris; heart failure (HF); ischaemic heart disease (IHD); cardiomyopathy; cardiac dysrhythmia; stenosis of a heart valve; hypertrophic cardiomyopathy (HCM); coronary heart disease; and other disorders, for example, diabetes and cancer. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, for example, in therapy.
    Type: Application
    Filed: November 20, 2014
    Publication date: April 14, 2016
    Inventors: Iain Robert Greig, Matteo Zanda, Chih-Chung Tseng